Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05059366 · ClinicalTrials.gov registry record · NA
Manual Ventilation Efficacy With MVG Device
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05059366: Completed NA study, sponsored by University of Miami.
NCT05059366 is a NA study that has completed, run by University of Miami. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05059366, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this research is to investigate the efficacy of the newly designed ventilation grip device (MVG device).
Primary Outcome
As measured using the ventilator machine in milliliters
Interventions
- DEVICE Manual Ventilation Grip Device
- OTHER 2VE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2021-08-20 |
| Phase | NA |
What the finished NCT05059366 record still lists
NCT05059366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Manual Ventilation Grip Device is the first listed.
NCT05059366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05059366 about?
NCT05059366 is a clinical study titled "Manual Ventilation Efficacy With MVG Device". The purpose of this research is to investigate the efficacy of the newly designed ventilation grip device (MVG device).
What is the current status of trial NCT05059366?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-08-11. Estimated completion is 2021-08-20.
What interventions are being tested in trial NCT05059366?
The interventions under investigation include: Manual Ventilation Grip Device (DEVICE), 2VE (OTHER).
Who is sponsoring clinical trial NCT05059366?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05059366's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI